| Kevin L Everett, MD | |
|
301 Prospect Ave, Syracuse, NY 13203-1807 | |
| (315) 448-5111 | |
| Not Available |
| Full Name | Kevin L Everett |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 31 Years |
| Location | 301 Prospect Ave, Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104890532 | NPI | - | NPPES |
| 105463 | Medicaid | AL | |
| CN0216 | Other | AL | MEDICARE TRAVELERS |
| 009959090 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME160201 (Florida) | Secondary |
| 207L00000X | Anesthesiology | 18720 (Alabama) | Secondary |
| 207L00000X | Anesthesiology | 319551 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital Health Center | Syracuse, NY | Hospital |
| Sarasota Memorial Hospital | Sarasota, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usa Health Anesthesia Billing Services Llc | 1153659123 | 136 |
| North American Partners In Anesthesia Llp | 7719885771 | 503 |
| Smh Physician Services Inc | 1355240177 | 592 |
News Archive
In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the first time, the key molecular mechanisms leading to visual degeneration and blindness.
› Verified 1 days ago
| Entity Name | University Of South Alabama |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746838 PECOS PAC ID: 3072425149 Enrollment ID: O20040115000773 |
News Archive
In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the first time, the key molecular mechanisms leading to visual degeneration and blindness.
› Verified 1 days ago
| Entity Name | Coastal Anesthesia, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588637169 PECOS PAC ID: 1052213519 Enrollment ID: O20040123001037 |
News Archive
In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the first time, the key molecular mechanisms leading to visual degeneration and blindness.
› Verified 1 days ago
| Entity Name | Sheridan Anesthesia Services Of Alabama, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225379159 PECOS PAC ID: 3971740465 Enrollment ID: O20130430000209 |
News Archive
In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the first time, the key molecular mechanisms leading to visual degeneration and blindness.
› Verified 1 days ago
| Entity Name | University Of South Alabama |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417408659 PECOS PAC ID: 3072425149 Enrollment ID: O20170118001161 |
News Archive
In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the first time, the key molecular mechanisms leading to visual degeneration and blindness.
› Verified 1 days ago
| Entity Name | Usa Health Anesthesia Billing Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629635818 PECOS PAC ID: 1153659123 Enrollment ID: O20190829000530 |
News Archive
In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the first time, the key molecular mechanisms leading to visual degeneration and blindness.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin L Everett, MD Po Box 851417, Mobile, AL 36685-1417 Ph: (251) 342-3000 | Kevin L Everett, MD 301 Prospect Ave, Syracuse, NY 13203-1807 Ph: (315) 448-5111 |
News Archive
In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the first time, the key molecular mechanisms leading to visual degeneration and blindness.
› Verified 1 days ago
Judith H Benedict, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 736 Irving Ave, Syracuse, NY 13210 Phone: 315-470-7828 Fax: 315-470-5811 | |
Dr. Joan E Thornton, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 301 Prospect Ave, Dept Of Anesthesia, Syracuse, NY 13203 Phone: 315-299-5451 Fax: 315-299-4710 | |
Dr. Mihael J Puc, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 301 Prospect Ave, Department Of Anesthesia, Syracuse, NY 13203 Phone: 315-448-5440 Fax: 315-472-5010 | |
Dr. Michael Hauser, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4720 | |
Fenghua Li, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4720 | |
James Caswell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4899 | |
Dr. Yinan Chen, M.D./PH.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4720 Fax: 315-464-4905 |